Fatigue, Depression, and Cortical Excitability in Systemic Lupus
NCT03165682 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 75
Last updated 2018-05-11
Summary
Systemic lupus erythematosus is a chronic inflammatory autoimmune disease with an unknown cause and many challenges. Whilst corticosteroids and effective immunosuppressive therapy have transformed the management of patients with active systemic lupus erythematosus, one of the major causes of morbidity in Systemic lupus erythematosus patients is chronic, debilitating fatigue.
Despite frequent occurrence of fatigue in Systemic Lupus Erythematosus, to the best of our knowledge, no studies have been directly performed to examine fatigue-related changes in cortical motor function in Systemic lupus erythematosus. In this study, we hypothesized that Systemic lupus erythematosus patients with fatigue and depression versus Systemic lupus erythematosus patients without fatigue and depression would present an alteration of motor cortex excitability.
Conditions
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Rania M. Gamal-El Din, Assistant Professor Dr · Assiut University
-
Eman M. El-Hakeem, Lecturer Dr · Assiut University
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-12-01
- Primary Completion
- 2019-08-30
- Completion
- 2019-12-30
More Related Trials
-
PRediction Of Flares In Lupus With autoantibodiEs and Chemokines
NCT04951427 ·Status: UNKNOWN
-
Establishing the Salience of Type 1 Interferon Pathway Blockade in the Central Mechanisms of SLE Related Fatigue
NCT06784076 ·Status: NOT_YET_RECRUITING
-
Anemia in Systemic Lupus Erythematosus Specially Refractory Type
NCT06210295 ·Status: NOT_YET_RECRUITING
-
Safety and Efficacy of Telitacicept in the Treatment of Systemic Lupus Erythematosus (SLE)
NCT06458972 ·Status: RECRUITING
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
Regulatory BCells in Systemic Lupus Erythematosus
NCT03178721 ·Status: UNKNOWN
-
Chemokine (CXCL13) as Anew Marker in Diagnosis of SLE
NCT03752983 ·Status: UNKNOWN
-
Bone Mineral Density in Patients with Childhood-onset Systemic Lupus Erythematous, in Relation to Disease Clinical Criteria
NCT06586359 ·Status: NOT_YET_RECRUITING
-
Study of Systemic Lupus Erythematosus
NCT00001372 ·Status: RECRUITING
-
Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus
NCT02456168 ·Status: COMPLETED
-
Anti-ficolin-2 Autoantibodies in Lupus Nephritis
NCT03063281 ·Status: COMPLETED
-
Association of Serum Interleukin-33 Levels With Clinical Manifestations in Systemic Lupus Erythematosus
NCT07149402 ·Status: NOT_YET_RECRUITING
-
Anti-ficolin-3 Antibodies in Lupus Nephritis
NCT03842787 ·Status: COMPLETED
-
Anti-ficolin-3 Autoantibodies in Lupus Nephritis
NCT02625831 ·Status: COMPLETED
-
Renal Survival in Patients with Lupus Nephritis
NCT06588192 ·Status: NOT_YET_RECRUITING
-
Autotaxin as Abiomarker in Systemic Lupus Erythematosus Patients
NCT06063668 ·Status: NOT_YET_RECRUITING
-
Photoprovocation Testing in Subjects With Cutaneous Lupus
NCT01516788 ·Status: COMPLETED ·Phase: NA
-
New Signaling Pathway Targeting Systemic Lupus Erythematosus
NCT03984227 ·Status: UNKNOWN
-
Fatigue in Lupus Intervention Programmes (FLIP)
NCT06308770 ·Status: RECRUITING ·Phase: NA
-
Comparison of Clinical and Serological Differences Among Juvenile, Adult, and Late-onset Systemic Lupus Erythematosus
NCT05724940 ·Status: UNKNOWN
-
Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)
NCT00987831 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
OMERACT SLE Delphi
NCT07136090 ·Status: NOT_YET_RECRUITING
-
Interleukin23 in Systemic Lupus
NCT06713187 ·Status: RECRUITING ·Phase: NA
-
The Efficacy and Safety of Telitacicept and Belimumab in Active Lupus Nephritis in the Real World: a Prospective Cohort Study
NCT05588830 ·Status: UNKNOWN
-
Serologically Active, Clinically Stable Systemic Lupus Erythematosus
NCT00000421 ·Status: COMPLETED ·Phase: PHASE2